全文获取类型
收费全文 | 16326篇 |
免费 | 1703篇 |
国内免费 | 407篇 |
专业分类
耳鼻咽喉 | 29篇 |
儿科学 | 553篇 |
妇产科学 | 287篇 |
基础医学 | 3291篇 |
口腔科学 | 220篇 |
临床医学 | 1614篇 |
内科学 | 3686篇 |
皮肤病学 | 190篇 |
神经病学 | 1547篇 |
特种医学 | 392篇 |
外科学 | 1163篇 |
综合类 | 1348篇 |
现状与发展 | 8篇 |
一般理论 | 2篇 |
预防医学 | 1126篇 |
眼科学 | 119篇 |
药学 | 1642篇 |
4篇 | |
中国医学 | 648篇 |
肿瘤学 | 567篇 |
出版年
2024年 | 46篇 |
2023年 | 332篇 |
2022年 | 362篇 |
2021年 | 923篇 |
2020年 | 693篇 |
2019年 | 691篇 |
2018年 | 661篇 |
2017年 | 649篇 |
2016年 | 637篇 |
2015年 | 750篇 |
2014年 | 1009篇 |
2013年 | 1428篇 |
2012年 | 855篇 |
2011年 | 937篇 |
2010年 | 761篇 |
2009年 | 704篇 |
2008年 | 759篇 |
2007年 | 767篇 |
2006年 | 612篇 |
2005年 | 541篇 |
2004年 | 426篇 |
2003年 | 415篇 |
2002年 | 304篇 |
2001年 | 278篇 |
2000年 | 235篇 |
1999年 | 223篇 |
1998年 | 205篇 |
1997年 | 187篇 |
1996年 | 163篇 |
1995年 | 182篇 |
1994年 | 158篇 |
1993年 | 163篇 |
1992年 | 142篇 |
1991年 | 119篇 |
1990年 | 133篇 |
1989年 | 109篇 |
1988年 | 71篇 |
1987年 | 78篇 |
1986年 | 74篇 |
1985年 | 111篇 |
1984年 | 109篇 |
1983年 | 73篇 |
1982年 | 90篇 |
1981年 | 71篇 |
1980年 | 50篇 |
1979年 | 32篇 |
1978年 | 31篇 |
1977年 | 22篇 |
1976年 | 15篇 |
1973年 | 12篇 |
排序方式: 共有10000条查询结果,搜索用时 234 毫秒
21.
年龄与代谢综合征的关系及防治对策 总被引:1,自引:0,他引:1
目的了解中老年人群年龄与多种代谢异常的聚集状况,为心脑血管疾病的一级预防提供依据。方法对744例中老年人按不同年龄分为5组,分析代谢综合征(MS)各项指标的变化规律及特点。结果年龄与肥胖呈明显负相关(P<0.001),与高血糖、高血压及冠心病、脑卒中呈明显正相关(P<0.05或0.001);40~60岁组MS的患病率基本一致,约为30%,70岁以后明显增加,到80岁时可高达51%(P<0.05或0.01);MS与冠心病和脑卒中的患病率均明显相关(P<0.05),随着临床指标个数的增加,冠心病的患病率增加了6.8%,脑卒中的患病率增加了7.44%。结论中年人群超重或肥胖的患病率明显高于老年组,应引起足够重视;随着年龄增长,代谢异常指标数目增多,尤其是≥3项指标的人数明显增加;MS作为心血管危险因素直接导致冠心病、脑卒中发病率增加。针对中老年人群MS的特点,制定相应的干预措施十分重要。 相似文献
22.
Non-alcoholic fatty liver disease, the metabolic syndrome and the risk of cardiovascular disease: the plot thickens. 总被引:5,自引:0,他引:5
G Targher 《Diabetic medicine》2007,24(1):1-6
Non-alcoholic fatty liver disease (NAFLD) affects a substantial proportion of the general population and is frequently associated with many features of the metabolic syndrome (MetS). Currently, the importance of NAFLD and its relationship with the MetS is being increasingly recognized, and this has stimulated an interest in the possible role of NAFLD in the development of atherosclerosis. Recent studies have reported the association of NAFLD with multiple classical and non-classical risk factors for cardiovascular disease (CVD). Moreover, there is a strong association between the severity of liver histopathology in NAFLD patients and greater carotid artery intima-media thickness and plaque, and lower endothelial flow-mediated vasodilation (as markers of subclinical atherosclerosis) independent of obesity and other MetS components. Finally, it has recently been demonstrated that NAFLD is associated with an increased risk of all-cause death and predicts future CVD events independently of other prognostic factors, including MetS components. Overall, therefore, the evidence from these recent studies strongly emphasizes the importance of assessing the global CVD risk in patients with NAFLD. Moreover, these novel findings suggest a more complex picture and raise the possibility that NAFLD, as a component of the MetS, might not only be a marker but also an early mediator of CVD. 相似文献
23.
24.
Sandra Fabian Heike Hesse Roland Grassme Ingo Bradl Annette Bernsdorf 《Pathophysiology》2005,12(4):281-287
The results of most reported studies show differences between the muscular activity of low back pain patients and healthy subjects, but the focus has usually been on trunk muscles only, and they have not involved work-related tests or exercises. The reintegration of chronic low back pain patients to job market is a common problem. Therefore assessment systems like the functional capacity evaluation (FCE) according to Isernhagen [S.J. Isernhagen, Work Injury: Management and Prevention, Aspen Publishers Inc., Gaithersburg, MD, 1988] are often used tools to determine the physical abilities and deficits of long-time incapacitated persons. The aim of the present study was to compare the healthy persons and chronic low back pain patients in performing a FCE-test and to analyse their muscular activation and motion patterns. The results indicate differences in the activation patterns of the groups in the test task “floor to waist lift” common in many occupations. 相似文献
25.
中、老年代谢综合征患者的临床特点分析 总被引:1,自引:0,他引:1
目的 比较中、老年代谢综合征(MS)患者的临床特点.方法 收集1996~2006年在解放军总医院门诊查体且符合中国人MS诊断标准(CDS)的947例中、老年患者的临床资料.其中老年人679例,中年人268例.分析中、老年患者MS各组分的差异,以及各组分的相关因素等.结果 947例患者中,男性582例(老年423例,中年159例),女性365例(老年256例,中年109例).老年男性患者的年龄大于老年女性(81.5±6.5 vs 74.5±8.8岁,P<0.01),老年男性的体重指数(BMI)高于中年男性(27.14±2.51 vs 25.98±2.38,P<0.01).老年患者的空腹、餐后血糖和收缩压均高于同性别的中年患者,而舒张压无显著差异.中年男性的甘油三酯高于老年男性.中年女性的高密度脂蛋白胆固醇高于男性.多元回归分析显示,男女患者空腹血糖均与餐后2h血糖有相关性(男性R2=0.463,P<0.05;女性R2=0.613,P<0.05).餐后2h血糖与年龄存在相关性(男性,R2=0.522,P<0.01;女性R2=0.716,P<0.05).收缩压与多种指标均有相关性,男性患者收缩压与年龄(R2=0.396,P<0.01)和舒张压(R2=0.535,P<0.05)均有相关性;女性患者的收缩压与BMI(R2=0.557,P<0.05)、舒张压(R2=0.434,P<0.05)、餐后2h血糖(R2=0.434,P<0.01)及空腹血糖(R2=0.473,P<0.05)均有相关性.Logistic回归分析示年龄(OR=2.1,95%CI:1.3~2.7)、空腹血糖(OR=1.7,95%CI:1.2~3.1)和收缩压(OR=1.4,95%CI:1.2~2.9)是预测代谢综合征组分含量的影响因素.结论 中老年代谢综合征患者的代谢指标有差异,年龄、空腹血糖和收缩压可作为代谢综合征的筛选指标. 相似文献
26.
Dario Roccatello Marco Formica Guido Cavalli Maria C. Amprimo Maria G. Pignatelli Paolo Costa Ruggero de Paulis Giacomo Quattrocchio rea Molino Gianbeppe Giordano 《Artificial organs》1990,14(1):69-72
Neutrophil oxidative metabolism, C3d and beta 2 microglobulin levels, were assessed in nine consecutive patients undergoing cardiopulmonary bypass surgery with polypropylene hollow fiber oxygenators for open cardiac operations. Generation of oxygen free radicals by neutrophils was measured as luminol-enhanced chemiluminescence after stimulation with opsonized Zymosan and phorbol myristate acetate. A significant increase in light emission was detected by using both of the chemiluminescence stimulators. Moreover, a remarkable and significant increase in C3d levels was found already at 10 min. Conversely minimal changes in levels of beta 2 microglobulin were detected during cardiopulmonary bypass surgery. These data suggest that the impact of the patient blood with the foreign surface of cardiopulmonary bypass results in activation of phagocyte cells with increased potential in oxygen consumption. These effects could be partially complement-mediated. 相似文献
27.
The effects of bilateral nucleus accumbens microinjections ofd-ala-met-enkephalinamide (DALA) were assessed in behavioral activation and lateral hypothalamic self-stimulation (LHSS) rate-frequency curve-shift paradigms in normal and accumbens 6-OHDA (4.0 µg) treated rats. Microinjections of DALA (2.5 µg/µl) in the behavioral activation paradigm had little effect on normal activity; however, DALA administered to 6-OHDA treated rats produced a significant overall increase in locomotion. The 6-OHDA DALA-induced locomotion effect peaked at 2 weeks after 6-OHDA treatment and then returned to baseline levels by week 5 posttreatment. Using LHSS, DALA tested over a range of doses (2.5, 5, 10, 20 µg/µl) displayed a weak biphasic reward effect only at the highest dose, which was characterized by an initial suppression followed by an elevation. DALA significantly depressed initial operant motor/performance in LHSS in a dose dependent fashion. Micro-injections of the normally ineffective low dose of DALA (2.5 µg/µl) following accumbens 6-OHDA treatment produced a significant LHSS reward decrease 2 weeks posttreatment, while LHSS motor/performance was relatively unaffected. Results are discussed in terms of opiate-dopamine and limbic-motor interactions. 相似文献
28.
29.
本文报告了应用稳定性同位素~(58)Fe对三组缺铁性贫血儿童,分别摄取平衡膳、平衡膳加大豆蛋白膳和平衡膳加大豆蛋白加维生素C膳时,各组儿童膳食铁的吸收率。测定结果顺次分别为12.0±3.6%、10.7±4.7%和18.1±3.6%。后者高于前二者,差异显著。据此,作者同意国际营养性贫血咨询小组(INACG)以及大多数学者的主张,即大豆制品不利于或降低膳食铁的生物利用率(bioavailability)。本文并结合实验讨论了本法的原理、操作技术及误差控制等问题,评价了本法在类似工作中的重要意义。 相似文献
30.
Maarten E Tushuizen Mathijs C Bunck Petra J Pouwels Jan Hein T van Waesberghe Michaela Diamant Robert J Heine 《Liver international》2006,26(8):1015-1017
BACKGROUND: Fat accumulation in the liver or non-alcoholic fatty liver disease (NAFLD) is regarded as a key pathogenic factor and component of the metabolic syndrome. It was reported that administration of the incretin mimetic exenatide reversed hepatic steatosis in an obese mouse model. We had the opportunity to study the effect of additional exenatide administration on liver fat content in a patient with type 2 diabetes. CASE REPORT: A 59-year-old male with poorly controlled type 2 diabetes was treated with exenatide in addition to metformin monotherapy. Following 44 weeks of exenatide therapy, mean the liver fat measured by liver spectroscopy declined from 15.8% to 4.3%. This dramatic decrease in liver fat was accompanied by significant beneficial changes in several cardiovascular disease risk factors and improvement of all liver enzymes, in particular alanine aminotransferase, the most important marker of liver steatosis. CONCLUSION: This case report suggests that the incretin mimetic exenatide decreases hepatic fat accumulation and may play a role in the future treatment of NAFLD, and the associated insulin resistance and cardiovascular risk factors in an ever-growing high-risk population. 相似文献